Definium Therapeutics Inc. Common Shares vs Fastenal Company Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Fastenal Company Common Stock trades at $50.49 (market cap $57.18B). The key difference: Fastenal Company Common Stock is far larger — about 12.1× Definium Therapeutics Inc. Common Shares's market cap, and Fastenal Company Common Stock pays a 1.93% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Fastenal Company Common Stock for 0 Days on average.
| DFTX | FAST | |
|---|---|---|
Market Cap | $4.71B | $57.18B |
Volume | 1,966,636 | 6,598,615 |
Sector | Health | Industrials |
52-Week High | $48.45 | $52.38 |
52-Week Low | $10.68 | $39.15 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $57.42B |
Dividend Yield | — | 1.93% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →